| Trial ID: | L6585 |
| Source ID: | NCT00627471
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
|
| Acronym: |
Malbec
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Insulin Glargine|DRUG: Insulin Glargine
|
| Outcome Measures: |
Primary: Mean difference in HbA1c (efficacy), 6 months | Secondary: Minor, severe and nocturnal Hypoglycaemic events (safety), from the begining of the treatment up to 5 days after the end of the study
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2010-06-02
|
| Locations: |
Sanofi-aventis administrative office Argentina, Buenos Aires, Argentina
|
| URL: |
https://clinicaltrials.gov/show/NCT00627471
|
